Site icon OncologyTube

Expanding the clinically actionable kidney cancer genome

Eliezer (Eli) Van Allen, MD of Dana-Farber Cancer Institute presents “Expanding the clinically actionable kidney cancer genome” at the 14th International Kidney Cancer Symposium.

Exit mobile version